Abstract:Cardiovascular disease is an important problem affecting global human health, and its incidence is increasing year by year. In recent years, more and more studies have shown that sex-determined region of Y (SRY)-related high mobility group-box 9 (SOX9) gene, as a highly conserved transcription factor, is widely involved in regulating cardiac dvelopment and cardiovascular disease progression at the level of gene transcription. SOX9, alone or in combination with other proteins, can bind to corresponding cis-acting elements in the downstream target gene promoter region and participate in regulating the expression of downstream heart development or cardiovascular disease-related genes. Therefore, SOX9 has the potential to be a new therapeutic target for the cardiovascular system. In this paper, the structure and function of SOX9 were systematically described, and the latest research progress of SOX9 in cardiac remodeling and vascular remodeling was summarized, in order to provide new ideas and methods for the prevention and treatment of cardiovascular system diseases in the future.